Carole Faig's most recent trade in Henry Schein Inc. was a trade of 2,844 Common Stock par value $0.01 per share done . Disclosure was reported to the exchange on March 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Henry Schein | Carole T. Faig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 2,844 | 5,448 (0%) | 0% | 0 | Common Stock par value $0.01 per share | |
| Henry Schein | Carole T. Faig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 2,604 | 2,604 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Cue Health Inc | Carole Faig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 63,300 | 130,030 | - | 0 | Common Stock | |
| Cue Health Inc | Carole Faig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2021 | 18,750 | 18,750 | - | 0 | Common Stock |